• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cardioneuroablation for management of cardioinhibitory vasovagal syncope and pacemaker complications.

作者信息

Stec Sebastian, Dobaj Łukasz, Śledź Arkadiusz, Stępień-Wałek Alicja M, Ton Victor, Śledź Janusz

机构信息

Research and Development Centre, MediNice, Rzeszów, Poland.

ELMedica, EP-Network, Skarżysko-Kamienna, Poland.

出版信息

HeartRhythm Case Rep. 2020 May 11;6(8):531-534. doi: 10.1016/j.hrcr.2020.04.021. eCollection 2020 Aug.

DOI:10.1016/j.hrcr.2020.04.021
PMID:32817835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7424299/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ff/7424299/52348987ce8f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ff/7424299/7c5b95626e7e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ff/7424299/43c8ff01b39c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ff/7424299/52348987ce8f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ff/7424299/7c5b95626e7e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ff/7424299/43c8ff01b39c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ff/7424299/52348987ce8f/gr3.jpg

相似文献

1
Cardioneuroablation for management of cardioinhibitory vasovagal syncope and pacemaker complications.心脏神经消融术用于治疗心脏抑制型血管迷走性晕厥和起搏器并发症。
HeartRhythm Case Rep. 2020 May 11;6(8):531-534. doi: 10.1016/j.hrcr.2020.04.021. eCollection 2020 Aug.
2
Cardioneuroablation for severe neurocardiogenic syncope.心脏神经消融术治疗严重神经心源性晕厥
Rev Port Cardiol. 2023 Oct;42(10):821-829. doi: 10.1016/j.repc.2023.02.012. Epub 2023 Jun 1.
3
Cardioinhibitory syncope: from pathophysiology to treatment-should we think on cardioneuroablation?心脏抑制性晕厥：从病理生理学到治疗——我们是否应该考虑心脏神经消融？
J Interv Card Electrophysiol. 2020 Nov;59(2):441-461. doi: 10.1007/s10840-020-00758-2. Epub 2020 May 7.
4
Cardioneuroablation for cardioinhibitory vasovagal syncope.心脏神经消融术治疗心脏抑制型血管迷走性晕厥。
J Cardiovasc Electrophysiol. 2021 Jun;32(6):1748-1753. doi: 10.1111/jce.15044. Epub 2021 Apr 27.
5
Permanent pacing versus cardioneuroablation for cardioinhibitory vasovagal syncope.永久性起搏与心脏神经消融术治疗心脏抑制型血管迷走性晕厥的比较
J Interv Card Electrophysiol. 2025 Mar;68(2):203-210. doi: 10.1007/s10840-022-01456-x. Epub 2022 Dec 23.
6
The use of a single chamber leadless pacemaker for the treatment of cardioinhibitory vasovagal syncope.使用单腔无导线起搏器治疗心脏抑制型血管迷走性晕厥。
Int J Cardiol Heart Vasc. 2019 Mar 28;23:100349. doi: 10.1016/j.ijcha.2019.100349. eCollection 2019 Jun.
7
Cardiac deceleration capacity as an indicator for cardioneuroablation in patients with refractory vasovagal syncope.心脏减速能力作为心脏神经消融术治疗难治性血管迷走性晕厥患者的指标。
Heart Rhythm. 2022 Apr;19(4):562-569. doi: 10.1016/j.hrthm.2021.12.007. Epub 2021 Dec 9.
8
Cardioneuroablation for the management of patients with recurrent vasovagal syncope and symptomatic bradyarrhythmias: the CNA-FWRD Registry.用于复发性血管迷走性晕厥和症状性缓慢性心律失常患者管理的心脏神经消融术：CNA-FWRD注册研究
J Interv Card Electrophysiol. 2025 Mar;68(2):183-191. doi: 10.1007/s10840-024-01789-9. Epub 2024 Mar 18.
9
Cardioneuroablation for Drug Refractory Vasovagal Syncope After COVID-19 Infection.新冠病毒感染后药物难治性血管迷走性晕厥的心脏神经消融术
JACC Case Rep. 2024 May 22;29(13):102373. doi: 10.1016/j.jaccas.2024.102373. eCollection 2024 Jul 3.
10
Improved health-related quality of life after cardioneuroablation in patients with vasovagal syncope.血管迷走性晕厥患者行心脏神经消融术后健康相关生活质量得到改善。
J Interv Card Electrophysiol. 2025 Mar;68(2):245-252. doi: 10.1007/s10840-022-01420-9. Epub 2022 Nov 11.

引用本文的文献

1
Shared Decision Making and Cardioneuroablation Allow Discontinuation of Permanent Pacing in Patients with Vagally Mediated Bradycardia.共同决策与心脏神经消融术可使迷走神经介导的心动过缓患者停用永久性起搏器
J Cardiovasc Dev Dis. 2023 Sep 11;10(9):392. doi: 10.3390/jcdd10090392.
2
Rationale and design of SAN.OK randomized clinical trial and registry: Comparison of the effects of evidence-based pacemaker therapy and cardioneuroablation in sinus node dysfunction.SAN.OK随机临床试验与注册研究的原理与设计：基于证据的起搏器治疗与心脏神经消融术治疗窦房结功能障碍的效果比较
Cardiol J. 2022;29(6):1031-1036. doi: 10.5603/CJ.a2022.0103. Epub 2022 Nov 17.
3

本文引用的文献

1
Cardiac parasympathetic modulation in the setting of radiofrequency ablation for atrial fibrillation.心房颤动射频消融术中的心脏副交感神经调制
Arch Med Sci. 2019 Apr 26;17(6):1716-1721. doi: 10.5114/aoms.2019.84717. eCollection 2021.
2
Relation of Fractionated Atrial Potentials With the Vagal Innervation Evaluated by Extracardiac Vagal Stimulation During Cardioneuroablation.心神经消融术中心外神经刺激评估的分心房电位与迷走神经支配的关系。
Circ Arrhythm Electrophysiol. 2020 Apr;13(4):e007900. doi: 10.1161/CIRCEP.119.007900. Epub 2020 Mar 19.
3
Right anterior ganglionated plexus: The primary target of cardioneuroablation?
Safety and efficacy of His bundle pacing validated by extracardiac vagal nerve stimulation (HIS-STORY).
经心外迷走神经刺激验证的希氏束起搏的安全性和有效性（希氏束起搏的历史）
Cardiol J. 2022;29(4):698-701. doi: 10.5603/CJ.a2022.0053. Epub 2022 Jun 15.
4
Ultrasound-guided imaging for vagus nerve stimulation to facilitate cardioneuroablation for the treatment of functional advanced atrioventricular block.超声引导成像用于迷走神经刺激以促进心脏神经消融治疗功能性晚期房室传导阻滞。
Indian Pacing Electrophysiol J. 2021 Nov-Dec;21(6):403-406. doi: 10.1016/j.ipej.2021.06.008. Epub 2021 Jun 26.
右侧前神经节丛：心脏神经消融的主要靶点？
Heart Rhythm. 2019 Oct;16(10):1545-1551. doi: 10.1016/j.hrthm.2019.07.018. Epub 2019 Jul 19.
4
2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society.2018年美国心脏病学会/美国心脏协会/心律学会关于心动过缓和心脏传导延迟患者评估与管理的指南：执行摘要：美国心脏病学会/美国心脏协会临床实践指南工作组及心律学会的报告
Heart Rhythm. 2019 Sep;16(9):e227-e279. doi: 10.1016/j.hrthm.2018.10.036. Epub 2018 Nov 6.
5
Cardioneuroablation using an anatomical approach: a new and promising method for the treatment of cardioinhibitory neurocardiogenic syncope.采用解剖学方法进行心脏神经消融：一种治疗心脏抑制型神经源性晕厥的新型且有前景的方法。
Kardiol Pol. 2018;76(12):1736-1738. doi: 10.5603/KP.a2018.0200. Epub 2018 Oct 19.
6
Simplified Method for Vagal Effect Evaluation in Cardiac Ablation and Electrophysiological Procedures.心脏消融和电生理手术中迷走神经效应评估的简化方法
JACC Clin Electrophysiol. 2015 Oct;1(5):451-460. doi: 10.1016/j.jacep.2015.06.008. Epub 2015 Aug 21.
7
2018 ESC Guidelines for the diagnosis and management of syncope.2018年欧洲心脏病学会晕厥诊断和管理指南。
Eur Heart J. 2018 Jun 1;39(21):1883-1948. doi: 10.1093/eurheartj/ehy037.
8
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.2017美国心脏病学会/美国心脏协会/美国心律学会晕厥患者评估与管理指南：执行摘要：美国心脏病学会/美国心脏协会临床实践指南工作组及心律学会报告
Circulation. 2017 Aug 1;136(5):e25-e59. doi: 10.1161/CIR.0000000000000498. Epub 2017 Mar 9.
9
Cardioneuroablation in the treatment of neurally mediated reflex syncope: a review of the current literature.心脏神经消融术治疗神经介导的反射性晕厥：当前文献综述
Turk Kardiyol Dern Ars. 2017 Dec;45(1):33-41. doi: 10.5543/tkda.2016.55250.
10
Catheter Ablation as a Treatment for Vasovagal Syncope: Long-Term Outcome of Endocardial Autonomic Modification of the Left Atrium.导管消融术治疗血管迷走性晕厥：左心房心内膜自主神经调节的长期疗效
J Am Heart Assoc. 2016 Jul 8;5(7):e003471. doi: 10.1161/JAHA.116.003471.